Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Deficiency Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01048671
What this trial is testing

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 482
Not applicableStudy completedNCT00001071
What this trial is testing

Stem Cells and Filgrastim

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Study completedNCT00068809
What this trial is testing

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 31
Post-approval studies (Phase 4)Study completedNCT00362687
What this trial is testing

GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance

Who this might be right for
HIV Infections
Gilead Sciences 50
Post-approval studies (Phase 4)Study completedNCT01684787
What this trial is testing

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Who this might be right for
Chronic Hepatitis C
Miguel Santin 80
Testing effectiveness (Phase 2)Study completedNCT02266992
What this trial is testing

Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study

Who this might be right for
Acquired Immune Deficiency Syndrome Virus
Sheffield Teaching Hospitals NHS Foundation Trust 28
Not applicableStudy completedNCT03158844
What this trial is testing

HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia

Who this might be right for
Hiv
University of Alabama at Birmingham 250
Large-scale testing (Phase 3)Study completedNCT01968551
What this trial is testing

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Who this might be right for
HIV-1HIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 158
Not applicableEnded earlyNCT04499651
What this trial is testing

Testing of a Navigation Intervention for Hepatitis C and HIV

Who this might be right for
HIV (Human Immunodeficiency Virus)Hepatitis C
University of California, Los Angeles 1
Early research (Phase 1)Study completedNCT00002353
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Large-scale testing (Phase 3)Study completedNCT00002245
What this trial is testing

The Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)WithdrawnNCT00488995
What this trial is testing

Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus
Pfizer
Not applicableLooking for participantsNCT07255157
What this trial is testing

Peripheral Helper T-cells in Common Variable ImmunoDeficiency

Who this might be right for
Common Variable Immunodeficiency
University Hospital, Bordeaux 60
Not applicableStudy completedNCT00218712
What this trial is testing

Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men

Who this might be right for
HIV Infections
University of California, San Francisco 488
Not applicableStudy completedNCT00002011
What this trial is testing

The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex

Who this might be right for
HIV Infections
Therakos
Large-scale testing (Phase 3)Study completedNCT00711009
What this trial is testing

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Who this might be right for
Human Immunodeficiency Virus Infection
Abbott 206
Post-approval studies (Phase 4)WithdrawnNCT00782301
What this trial is testing

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Who this might be right for
Hepatitis BHuman Immunodeficiency VirusHepatitis C, Chronic
ViiV Healthcare
Not applicableStudy completedNCT03367130
What this trial is testing

Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal

Who this might be right for
HIV InfectionsAntiretroviral TherapyHIV Seropositivity
Tokyo University 468
Not applicableUnknownNCT03436407
What this trial is testing

Evaluation of Implementation of Pre-exposure Prophylaxis (PrEP) in Norway

Who this might be right for
HivSexually Transmitted DiseasesMental Health Wellness 1
Oslo University Hospital 500
Not applicableStudy completedNCT04849767
What this trial is testing

National Survey About Trajectory and Life Conditions of HIV Trans People in France

Who this might be right for
HIV Seropositivity
ANRS, Emerging Infectious Diseases 536
Next Page